药物输送市场份额报告| 2023-2028 年全球展望

  • Report Code : TIPRE00029924
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 314
Buy Now

[研究报告] 预计给药市场规模将从2022年的20998.567亿美元增长到2028年的32545.942亿美元;预计 2023 年至 2028 年复合年增长率为 7.7%。

药物输送市场根据给药途径、分销渠道、最终用户进行细分和地理。该报告提供了见解和深入的市场分析,强调了各地区领先市场参与者的驱动因素、趋势、机会和竞争格局分析等参数。它还包括对 COVID-19 大流行对主要地区影响的分析。

市场洞察

对无创给药系统不断增长的需求推动了给药市场

无创给药通常是指跨生物领域的无痛给药方法粘膜表面或皮肤的屏障。这种药物输送方法可以改善药物的获取、治疗方案的依从性以及更好的药物安全性。由于与注射给药相比具有明显的优势,患者更喜欢无创给药途径。研究发现,通过非侵入性方法给药时,患者的依从性要高得多,因为他们在手术过程中感受到的疼痛减轻了。随着医疗设备和透皮给药技术的改进,无创给药方式现已准备好与传统的口服和注射给药途径竞争。局部给药、透皮主动给药(设备辅助增强渗透)、透皮被动给药、经眼膜、跨粘膜以及吸入药物通过肺泡膜给药是一些流行的非侵入性给药方法。

低排斥率、易于给药、方便且耐用,使 TDDS 成为最具吸引力的药物输送方法。除了医疗机构的药物管理之外,TDDS 还可用于护肤行业的不同程序。由于该方法主要涉及局部给药,因此可以防止药物非特异性递送至非靶向组织。 TDDS 的发展可能有助于控制心血管和中枢神经系统疾病、遗传性疾病、糖尿病、神经肌肉疾病和传染病(包括局部病症)的患病率,同时推动疫苗接种的进步和患者对自我给药药物的偏好的进步长期治疗。

通过无创方法给药涉及减少给药频率和简化给药方案。此外,这些输送系统可以显着降低临床使用成本,因为患者可以通过这些方法自行给药。在许多情况下,采用无创给药系统的药物的制造成本低于注射剂的生产成本。例如,吸入胰岛素已成为治疗糖尿病的耐受性良好且首选的方式。因此,对无创给药系统不断增长的需求推动了给药市场的增长。

战略见解

基于给药途径的洞察

根据给药途径,给药市场分为口服给药、注射给药、经粘膜给药、局部给药、植入式给药和眼部给药。 2022年,注射给药领域占据给药市场的最大份额。然而,预计局部给药领域在预测期内的复合年增长率最高。由于递送至目标部位的速度和有效性以及改善的患者体验,注射给药被认为是有效的给药途径之一。注射有助于将药物、疫苗或任何其他治疗剂注射到体内。通过消化道以外的途径的药物递送技术被称为肠胃外。肠胃外给药途径包括肌内、皮下和静脉内。无针注射器的发展降低了糖尿病患者针刺伤害的风险,从而改善了胰岛素药物输送。

由于技术进步,注射剂在复杂的药物输送过程中的使用越来越多。注射给药系统和具有卓越功能的下一代注射装置的推出促进了注射给药领域的全球给药市场的增长。

分销渠道-基于洞察

根据分销渠道,给药市场分为医院药房、零售药房和在线药房。医院药房细分市场在 2022 年占据最大市场份额,预计在预测期内将创下最高复合年增长率。

按路线划分的药物输送市场行政管理部2022 年-2028 年

基于最终用户的见解

根据最终用户,给药市场分为医院和诊所、家庭护理机构和其他最终用户。医院和诊所细分市场在 2022 年占据最大的市场份额,预计在预测期内将创下最高的复合年增长率。

药物输送市场参与者采用有机策略,例如产品推出和扩展,以扩大其地理足迹和产品组合并满足不断增长的需求。市场参与者采用的无机增长战略使他们能够扩大业务并增强其地域影响力。此外,这些增长战略可帮助公司增强客户群并扩大产品组合。

  • 2022 年 9 月,Becton、Dickinson、该公司推出了下一代玻璃预充式注射器 (PFS),并为疫苗 PFS 的性能制定了新标准,并在可加工性、外观、污染和完整性方面制定了新的更严格的规范。新型 BD Effivax 玻璃预充式注射器是与领先的制药公司合作设计的,以满足疫苗生产复杂且不断变化的需求。
  • 2022 年 6 月,辉瑞公司加强了其对美国制造,在密歇根州卡拉马祖工厂投资 1.2 亿美元,实现在美国的生产,以支持其 COVID-19 口服治疗药物 PAXLOVID(尼马曲韦片剂和利托那韦片剂)。这项投资扩大了用于生产 nirmatrelvir 的活性药物成分 (API) 和注册原材料 (RSM) 的生产。

公司简介

  • 贝克顿迪金森公司           
  • 诺和诺德公司
  • 强生公司约翰逊               
  • 波士顿科学公司
  • 辉瑞公司                            
  • 百特国际公司             
  • Gerresheimer AG                ;     
  • Kindeva 药物输送 LP           
  • 葛兰素史克公司                 
  • 博士健康公司           
  • 诺华公司              ;            
  • Sever Pharma Solutions
  • 勃林格殷格翰国际
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the drug delivery market?

The drug delivery market is analyzed in the basis of route of administration, distribution channel, and end user. Based on route of administration, is segmented into oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest market share in 2022. However, topical drug delivery segment is anticipated to register the highest CAGR during the forecast period.

Who are the major players in market the drug delivery market?

The drug delivery market majorly consists of the players such as Pfizer Inc, Johnson & Johnson, Becton Dickinson and Co, Novo Nordisk AS, Boston Scientific Corp, Baxter International Inc, Gerresheimer AG, Kindeva Drug Delivery LP, GlaxoSmithKline Plc, Bausch Health Companies, Novartis AG, Sever Pharma Solutions, Boehringer Ingelheim International.

What is the drug delivery?

Drug delivery are various methodologies used to inject drugs or chemicals into the body. Some of the drug delivery available in the market include, transmucosal, oral, injectable, topical, implantable, and ocular among others. Drug delivery are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.

What are the driving factors for the global drug delivery market across the world?

The factors that are driving the growth of market are growth are rising incidence of chronic diseases, growing demand for noninvasive drug delivery systems, and increasing R&D expenditures in pharmaceutical companies propel the market growth.

The List of Companies - Drug Delivery Market

  1. Becton, Dickinson and Co                
  2. Novo Nordisk AS                  
  3. Boston Scientific Corp
  4. Baxter International Inc    
  5. Gerresheimer AG                
  6. Kindeva Drug Delivery LP                 
  7. GlaxoSmithKline Plc           
  8. Bausch Health Companies               
  9. Novartis AG           
  10. Boehringer Ingelheim International
  11. Sever Pharma Solutions
  12. Pfizer Inc.               
  13. Johnson & Johnson.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports